Unsuspected PE seldom linked to death in cancer patients

October 9, 2012
Unsuspected PE seldom linked to death in cancer patients
Unsuspected pulmonary embolism is not associated with an increased risk of death in cancer patients when compared to patients without pulmonary embolism, according to research published in the October issue of the Journal of Thrombosis and Haemostasis.

(HealthDay)—Unsuspected pulmonary embolism (UPE) is not associated with an increased risk of death in cancer patients when compared to patients without pulmonary embolism (PE), according to research published in the October issue of the Journal of Thrombosis and Haemostasis.

M. Sahut D'Izarn, M.D., of the Hôpitaux de Paris, and colleagues conducted a retrospective case-control study involving 132 without PE and 65 cancer patients with clinically suspected PE to assess the risk of UPE in cancer patients.

The researchers found that, overall, 40.9 percent of UPE patients had symptoms suggestive of PE. Patients with adenocarcinoma, advanced age, recent chemotherapy, performance status greater than 2, and previous were more likely to have UPE. Six-month mortality was not statistically significantly different for patients with UPE compared with those without PE. UPE patients were more likely to have and chemotherapy and less likely to have proximal clots than those with clinically suspected PE. Recurrent venous thromboembolism occurred in 6.1 percent of patients with UPE and 7.7 percent of patients with symptomatic PE.

"In conclusion, in the context of a retrospective study, a high proportion of patients with UPE have respiratory symptoms preceding the diagnosis of PE. This may prompt the attention of the oncologist when a patient at risk for UPE complains of dyspnea or chest pain," the authors write. "The increased mortality rate of patients with UPE seems to be mainly related to their underlying condition and, especially, poor performance status rather than to UPE itself."

One author disclosed to the pharmaceutical industry.

Explore further: Unsuspected PE does not up mortality risk in cancer patients

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Unsuspected PE does not up mortality risk in cancer patients

August 6, 2012
(HealthDay) -- Cancer patients with an unsuspected pulmonary embolism (UPE) do not have an increased mortality risk and have a similar risk of recurrent venous thromboembolism (VTE) to those with clinically suspected pulmonary ...

Patients with inflammatory bowel disease appear to be at increased risk for post-operative DVT, PE

October 17, 2011
Patients with inflammatory bowel disease (IBD) undergoing surgery may be more likely to develop deep vein thrombosis (DVT; blood clot in a deep vein in the thigh or leg) or pulmonary embolism (PE; blood clot in blood vessels ...

ACP recommends new approach to prevent venous thromboembolism in hospitalized patients

October 31, 2011
In a new clinical practice guideline published today in Annals of Internal Medicine, the American College of Physicians (ACP) recommends that doctors assess the risk of thromboembolism and bleeding in patients hospitalized ...

Risk of pulmonary embolism greatest during first week following total joint replacement

February 7, 2012
The elevated risk of pulmonary embolism (PE) – a blood clot that travels from the leg to the lungs – following total joint replacement (TJR) surgery has been well established, yet little is known about the natural ...

Recommended for you

Presurgical targeted therapy delays relapse of high-risk stage 3 melanoma

January 17, 2018
A pair of targeted therapies given before and after surgery for melanoma produced at least a six-fold increase in time to progression compared to standard-of-care surgery for patients with stage 3 disease, researchers at ...

Dulling cancer therapy's double-edged sword

January 17, 2018
Researchers have discovered that killing cancer cells can actually have the unintended effect of fueling the proliferation of residual, living cancer cells, ultimately leading to aggressive tumor progression.

Researchers develop swallowable test to detect pre-cancerous Barrett's esophagus

January 17, 2018
Investigators at Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center have developed a simple, swallowable test for early detection of Barrett's esophagus that offers promise ...

Scientists zoom in to watch DNA code being read

January 17, 2018
Scientists have unveiled incredible images of how the DNA code is read and interpreted—revealing new detail about one of the fundamental processes of life.

T-cells engineered to outsmart tumors induce clinical responses in relapsed Hodgkin lymphoma

January 16, 2018
WASHINGTON-(Jan. 16, 2018)-Tumors have come up with ingenious strategies that enable them to evade detection and destruction by the immune system. So, a research team that includes Children's National Health System clinician-researchers ...

Researchers identify new treatment target for melanoma

January 16, 2018
Researchers in the Perelman School of Medicine at the University of Pennsylvania have identified a new therapeutic target for the treatment of melanoma. For decades, research has associated female sex and a history of previous ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.